Abstract
Background: Aceclofenac is a phenylacetic acid derivative belongs to the group of nonsteroidal anti-inflammatory drug. It is commonly used in the treatment of pain and various inflammatory disorders. It is well tolerated, with most adverse events being minor and reversible and affecting mainly the GI system.
Case Report: Here, we report a rare occurrence of non-pigmenting fixed drug eruption after the use of aceclofenac in a 19 year old female.
Keywords: Aceclofenac, non-pigmenting fixed drug eruption, NSAID, GI system, vitamin B complex, vitamin D plus.
Graphical Abstract
Current Drug Safety
Title:Non-pigmenting Fixed Drug Eruption: An Unusual Adverse Reaction to Aceclofenac
Volume: 13 Issue: 3
Author(s): Neel Prabha*Namrata Chhabra
Affiliation:
- Department of Dermatology, Venereology & Leprology, All India Institute of Medical Sciences, GE Rd, Tatibandh, Raipur, Chhattisgarh,India
Keywords: Aceclofenac, non-pigmenting fixed drug eruption, NSAID, GI system, vitamin B complex, vitamin D plus.
Abstract: Background: Aceclofenac is a phenylacetic acid derivative belongs to the group of nonsteroidal anti-inflammatory drug. It is commonly used in the treatment of pain and various inflammatory disorders. It is well tolerated, with most adverse events being minor and reversible and affecting mainly the GI system.
Case Report: Here, we report a rare occurrence of non-pigmenting fixed drug eruption after the use of aceclofenac in a 19 year old female.
Export Options
About this article
Cite this article as:
Prabha Neel *, Chhabra Namrata , Non-pigmenting Fixed Drug Eruption: An Unusual Adverse Reaction to Aceclofenac, Current Drug Safety 2018; 13 (3) . https://dx.doi.org/10.2174/1574886313666180726104812
DOI https://dx.doi.org/10.2174/1574886313666180726104812 |
Print ISSN 1574-8863 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3911 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Taking Advantage of Viral Immune Evasion: Virus-Derived Proteins Represent Novel Biopharmaceuticals
Current Medicinal Chemistry NO Chimeras as Therapeutic Agents in Alzheimers Disease
Current Alzheimer Research Melatonin Redox Activity. Its Potential Clinical Applications in Neurodegenerative Disorders
Current Topics in Medicinal Chemistry Capsaicin-Sensitive Nociceptive Innervation of the Dura Mater: Implications for the Pathomechanism of Headache
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Comparative Analysis of Stage Specific Gene Regulation of Apicomplexan Parasites: Plasmodium falciparum and Toxoplasma gondii
Infectious Disorders - Drug Targets Colchicine: An Ancient Drug with Multiple Benefits
Current Pharmaceutical Design Post-Wortmannin Era: Novel Phosphoinositide 3-Kinase Inhibitors with Potential Therapeutic Applications
Current Enzyme Inhibition Current Landscape of Natural Products against Coronaviruses: Perspectives in COVID-19 Treatment and Anti-viral Mechanism
Current Pharmaceutical Design Current Research and Use of Mesenchymal Stem Cells in the Therapy of Autoimmune Diseases
Current Stem Cell Research & Therapy Mechanisms Involved in the Increased Hemolysis in the Fetus and Newborn
Current Pediatric Reviews Perspectives on Sesquiterpene Lactones in Inflammation and Cancer
Current Drug Targets Structural Models of Class A G Protein-Coupled Receptors as a Tool for Drug Design: Insights on Transmembrane Bundle Plasticity
Current Topics in Medicinal Chemistry Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue
Current Medicinal Chemistry The Epidermis as a Model for Tissue Engineering
Current Tissue Engineering (Discontinued) Comparative Study of LC/MS and EMIT in Therapeutic Monitoring of Carbamazepine and its Clinical Applications
Current Pharmaceutical Analysis Meet Our Editorial Board Member
Recent Patents on Inflammation & Allergy Drug Discovery Current and Future Drugs for Appetite Regulation and Obesity Treatment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Neuroprotection in Hypoxic-Ischemic Brain Injury Targeting Glial Cells
Current Pharmaceutical Design VEGF, Angiopoietin-1 and -2 in Bronchial Asthma: New Molecular Targets in Airway Angiogenesis and Microvascular Remodeling
Recent Patents on Inflammation & Allergy Drug Discovery Jun Dimerization Protein 2 in Oxygen Restriction; Control of Senescence
Current Pharmaceutical Design